Literature DB >> 29683287

Evidence for biofilms in onychomycosis.

Aditya K Gupta1,2, Kelly A Foley3.   

Abstract

Onychomycosis is a difficult to treat fungal infection of the nails. The chronic nature of onychomycosis contributes to high recurrence rates and the difficulty in treating both dermatophyte and non-dermatophyte infections. It has been hypothesized that the formation of biofilms, sessile, multicellular communities of fungi surrounded by a protective extracellular matrix, allow for fungi to evade current antifungal therapies and contribute to observed antifungal resistance. This review presents the experimental evidence that has accumulated in recent years implicating biofilms in the pathogenesis of onychomycosis. Dermatophytes, non-dermatophyte molds, and yeasts form biofilms in vitro and a model using ex vivo healthy nail fragments has demonstrated biofilm formation on nails for dermatophyte, Candida, and Fusarium species. Implications for disease management are discussed with further research required to incorporate biofilm formation into future drug/device evaluation and treatment protocols.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29683287     DOI: 10.23736/S0392-0488.18.06001-7

Source DB:  PubMed          Journal:  G Ital Dermatol Venereol        ISSN: 0392-0488            Impact factor:   2.011


  9 in total

1.  Rhodotorula sp. and Trichosporon sp. are more Virulent After a Mixed Biofilm.

Authors:  Isabele Carrilho Jarros; Isabella Letícia Esteves Barros; Andressa Prado; Jakeline Luiz Corrêa; Amanda Milene Malacrida; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Mycopathologia       Date:  2021-12-02       Impact factor: 2.574

2.  2-Hydroxychalcone as a Potent Compound and Photosensitizer Against Dermatophyte Biofilms.

Authors:  Níura Madalena Bila; Caroline Barcelos Costa-Orlandi; Carolina Orlando Vaso; Jean Lucas Carvalho Bonatti; Letícia Ribeiro de Assis; Luís Octavio Regasini; Carla Raquel Fontana; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini
Journal:  Front Cell Infect Microbiol       Date:  2021-05-13       Impact factor: 5.293

3.  A Week of Oral Terbinafine Pulse Regimen Every Three Months to Treat all Dermatophyte Onychomycosis.

Authors:  Anarosa B Sprenger; Katia Sheylla Malta Purim; Flávia Sprenger; Flávio Queiroz-Telles
Journal:  J Fungi (Basel)       Date:  2019-09-04

Review 4.  Onychomycosis: An Updated Review.

Authors:  Alexander K C Leung; Joseph M Lam; Kin F Leong; Kam L Hon; Benjamin Barankin; Amy A M Leung; Alex H C Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020

5.  Printing Drugs onto Nails for Effective Treatment of Onychomycosis.

Authors:  Thomas D Pollard; Margherita Bonetti; Adam Day; Simon Gaisford; Mine Orlu; Abdul W Basit; Sudaxshina Murdan; Alvaro Goyanes
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

Review 6.  Updated Perspectives on the Diagnosis and Management of Onychomycosis.

Authors:  Julianne M Falotico; Shari R Lipner
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-15

Review 7.  Dermatophytomas: Clinical Overview and Treatment.

Authors:  Aditya K Gupta; Tong Wang; Elizabeth A Cooper
Journal:  J Fungi (Basel)       Date:  2022-07-19

8.  Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Trichophyton rubrum Biofilms.

Authors:  Caroline Barcelos Costa-Orlandi; Luis R Martinez; Níura Madalena Bila; Joel M Friedman; Adam J Friedman; Maria José S Mendes-Giannini; Joshua D Nosanchuk
Journal:  Front Cell Infect Microbiol       Date:  2021-07-15       Impact factor: 5.293

9.  The Success of Topical Treatment of Onychomycosis Seems to Be Influenced by Fungal Features.

Authors:  Vanessa Vasconcellos-Pontello; Flávia Franco Veiga; Marina Cristina Gadelha; Marielen Ribeiro; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-09       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.